KR19980703647A - 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 - Google Patents

베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 Download PDF

Info

Publication number
KR19980703647A
KR19980703647A KR1019970707046A KR19970707046A KR19980703647A KR 19980703647 A KR19980703647 A KR 19980703647A KR 1019970707046 A KR1019970707046 A KR 1019970707046A KR 19970707046 A KR19970707046 A KR 19970707046A KR 19980703647 A KR19980703647 A KR 19980703647A
Authority
KR
South Korea
Prior art keywords
active ingredient
formula
valsartan
ingredient component
benazepril
Prior art date
Application number
KR1019970707046A
Other languages
English (en)
Korean (ko)
Inventor
마르크 드가스파로
랜디 리 웨브
데이비드 사울 코헨
Original Assignee
베르너발데크
노파르티스아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르너발데크, 노파르티스아게 filed Critical 베르너발데크
Publication of KR19980703647A publication Critical patent/KR19980703647A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
KR1019970707046A 1995-04-07 1996-04-02 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 KR19980703647A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1012/95 1995-04-07
CH101295 1995-04-07

Publications (1)

Publication Number Publication Date
KR19980703647A true KR19980703647A (ko) 1998-12-05

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970707046A KR19980703647A (ko) 1995-04-07 1996-04-02 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물

Country Status (15)

Country Link
EP (1) EP0820302A1 (cs)
JP (1) JPH11503139A (cs)
KR (1) KR19980703647A (cs)
CN (1) CN1181019A (cs)
AU (1) AU5399096A (cs)
BR (1) BR9604818A (cs)
CA (1) CA2214143A1 (cs)
CZ (1) CZ313897A3 (cs)
HU (1) HUP9801593A2 (cs)
MX (1) MX9707683A (cs)
NO (1) NO974400D0 (cs)
PL (1) PL322529A1 (cs)
SK (1) SK133897A3 (cs)
TR (1) TR199701121T1 (cs)
WO (1) WO1996031234A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (ja) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
AR032152A1 (es) * 2000-04-12 2003-10-29 Novartis Ag Uso de una combinacion de compuestos terapeuticos organicos para la fabricacion de un medicamento, un agente terapeutico, y una composicion farmaceutica
CA2415962C (en) * 2000-07-19 2010-07-06 Novartis Ag Valsartan salts
EP1671632A1 (en) * 2000-08-22 2006-06-21 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
WO2004019876A2 (en) * 2002-08-28 2004-03-11 Curis, Inc. Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
JP5612674B2 (ja) 2009-05-20 2014-10-22 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミットベシュレンクテル ハフツング テルミサルタンを含む経口懸濁液
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
MX2016010011A (es) * 2014-01-31 2016-10-07 Janssen Pharmaceutica Nv Metodos para tratar y prevenir trastornos renales y trastornos del higado graso.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148632T1 (de) * 1990-05-11 1997-02-15 Pfizer Synergistische therapeutische zusammensetzungen und verfahren
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
AU5399096A (en) 1996-10-23
BR9604818A (pt) 1998-06-09
MX9707683A (es) 1997-12-31
EP0820302A1 (en) 1998-01-28
CZ313897A3 (cs) 1998-01-14
NO974400L (no) 1997-09-23
PL322529A1 (en) 1998-02-02
WO1996031234A1 (en) 1996-10-10
CA2214143A1 (en) 1996-10-10
JPH11503139A (ja) 1999-03-23
HUP9801593A2 (hu) 1999-01-28
CN1181019A (zh) 1998-05-06
TR199701121T1 (xx) 1998-03-21
NO974400D0 (no) 1997-09-23
SK133897A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
EP2322174B1 (en) Combined use of valsartan and calcium channel blockers for therapeutic purposes
KR19980703647A (ko) 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물
US6395728B2 (en) Method of treatment and pharmaceutical composition
CN102091330B (zh) 含有缬沙坦和nep抑制剂的药物组合物
TWI508726B (zh) 治療心房纖維性顫動之方法
CZ305341B6 (cs) Farmaceutická kompozice, souprava obsahující účinné látky této kompozice a použití kombinace účinných látek této kompozice
US6204281B1 (en) Method of treatment and pharmaceutical composition
CN1655819A (zh) 包含肾素抑制剂、钙通道阻断剂和利尿药的药物组合物
Morganti et al. Aliskiren: the first direct renin inhibitor available for clinical use
Szucs Cilazapril: a review
JPH04230220A (ja) 医薬組成物
Pitt et al. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial
JP4609877B2 (ja) 慢性拒絶反応抑制剤
EP1146872A1 (en) Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
WO2004075892A2 (en) Combination therapy for hypertension using lercanidipine and an angiotensin ii receptor blocker
ZA200106022B (en) Use of angiotensin II receptor antagonists for treating acute myocardial infarction.
US20040147566A1 (en) Lisinopril/lercanidipine combination therapy
Su et al. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure: Differential acute effects according to the renin-angiotensin system activation
Sierra et al. Role of the selective aldosterone receptor blockers in arterial hypertension
JP2006504800A (ja) リシノプリル／レルカニジピンの組み合わせ治療
Waeber et al. Antihypertensive Agents: Mechanisms of Drug Action
WO2003007964A1 (fr) Remede ou agent preventif de cardiopathie ou d'anevrysme contenant un compose d'inhibition de la chymase
KR20230006884A (ko) 뇌 아미노펩티다제 a 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물
Padia et al. Renin inhibition as a new strategy to combat cardiovascular disease
Ks Siegl et al. Cardiovascular and Renal Review: Pharmacology of Angiotensin II Receptor Antagonists: Comparison with Renin Inhibitors and Angiotensin-Converting Enzyme Inhibitors

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid